Dequadin oral solution - gingivitis, stomatitis, tonsillitis 28 ml

Product Description

Eurospital

Treatment of Gingivitis, Stomatitis, Tonsillitis; 28ml bottle

Active ingredients

DEQUADIN 0.5% oral mucosal solution 100 ml of oral mucosal solution contain: Active ingredient: dequalinium chloride 0.5 g. DEQUADIN 0.5% oral mucosal solution and DEQUADIN 0.5% oral mucosal spray contain propylene glycol.

Excipients

DEQUADIN 0.5% oral mucosal solution: Propylene glycol, ethyl alcohol, saccharin, purified water, benzyl alcohol, rose flavoring, geranium essential oil.

Therapeutic indications

Oral mucosal solution: Topical treatment for gingivitis, stomatitis, tonsillitis, pharyngitis. After tooth extractions, DEQUADIN oral mucosal solution is useful for the prophylaxis of infections.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. In children under three years of age, especially if predisposed to laryngospasm or convulsions.

Dosage

DEQUADIN oral mucosal solution: Adults: apply locally every 2–3 hours: use a brush or a cotton ball wrapped around a stick or the special spray dispenser in the 10 ml bottle. Children over three years of age: 2 to 5 local applications per day. For the topical treatment of moderate or mild infections, DEQUADIN oral mucosal solution can be used for gargling or mouthwash: dilute 10–20 drops of solution in a glass of water and apply 3 times a day. It is advisable to keep the mouth open and not swallow saliva for a few minutes after applying the solution: this will ensure maximum therapeutic efficacy. Do not exceed the recommended doses.

Warnings and precautions

The use, especially if prolonged, of topical products can give rise to sensitization phenomena; if this occurs, treatment must be suspended and appropriate therapy instituted. The same applies in the event of the development of resistant microorganisms. Oral mucosa spray and oral mucosa solution: use should be limited to lesions of the mouth and throat.

Interactions

Avoid the simultaneous use of other antiseptics and detergents.

Side effects

The use of the medicinal product may cause local irritation. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

Pregnancy and breastfeeding

There are no known contraindications.